Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-07 9:14 pm Purchase | 2026-03-31 | 13D | ONKURE THERAPEUTICS, INC. CLAS OKUR | AI Biotechnology LLC | 9,091,532 19.990% | 9,091,532 (New Position) | Filing History |
| 2026-03-02 5:53 pm Purchase | 2026-02-26 | 13D | ZURA BIO LTD ZURA | AI Biotechnology LLC | 19,699,071 18.200% | 5,372,981 (+37.50%) | Filing History |
| 2025-05-28 5:28 pm Purchase | 2025-05-21 | 13D | ZURA BIO LTD ZURA | AI Biotechnology LLC | 14,326,090 19.900% | 14,326,090 (New Position) | Filing History |
| 2025-03-31 4:01 pm Purchase | 2025-03-24 | 13G | SURROZEN INC SRZN | AI Biotechnology LLC | 844,563 9.900% | 844,563 (New Position) | Filing History |
| 2023-11-13 08:24 am Purchase | 2023-11-01 | 13D | VYNE THERAPEUTICS INC VYNE | AI Biotechnology LLC | 3,201,980 19.990% | 3,201,980 (New Position) | Filing History |